A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis

Arthritis and Rheumatism

Volumn 63, Issue 1, 2011, Pages 247-256

  Manetti, Mirko ^a   Allanore, Yannick ^b   Revillod, Lucile ^b   Fatini, Cinzia ^a   Guiducci, Serena ^a   Cuomo, Giovanna ^c   Bonino, Claudia ^d   Riccieri, Valeria ^e   Bazzichi, Laura ^f   Liakouli, Vasiliki ^g   Cipriani, Paola ^g   Giacomelli, Roberto ^g   Abbate, Rosanna ^a   Bombardieri, Stefano ^f   Valesini, Guido ^e   Montecucco, Carlomaurizio ^d   Valentini, Gabriele ^c   Ibba Manneschi, Lidia ^a   Matucci Cerinic, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; UROKINASE RECEPTOR;

ADULT; ALLELE; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL ULCERATION; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PULMONARY HYPERTENSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; ULCER; VASCULAR DISEASE;

ADULT; AGED; ALLELES; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SCLERODERMA, SYSTEMIC; VASCULAR DISEASES;

EID: 78650796872     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30101     Document Type: Article

References (34)

1. Varga J, Abraham D,. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007; 117: 557-67.
2. Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M,. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med 2010; 14: 1241-54.
3. Guiducci S, Giacomelli R, Matucci-Cerinic M,. Vascular complications of scleroderma. Autoimmun Rev 2007; 6: 520-3.
4. Allanore Y, Wipff J, Kahan A, Boileau C,. Genetic basis for systemic sclerosis. Joint Bone Spine 2007; 74: 577-83.
5. Blasi F, Carmeliet P,. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 2002; 3: 932-43.
6. Ragno P,. The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. Cell Mol Life Sci 2006; 63: 1028-37.
7. D'Alessio S, Fibbi G, Cinelli M, Guiducci S, Del Rosso A, Margheri F, et al. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. Arthritis Rheum 2004; 50: 3275-85.
8. Margheri F, Manetti M, Serrati S, Nosi D, Pucci M, Matucci-Cerinic M, et al. Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, β2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells. Arthritis Rheum 2006; 54: 3926-38.
9. Bandinelli F, Bartoli F, Perfetto E, Del Rosso A, Moggi-Pignone A, Guiducci S, et al. The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (α1 ciclodestryn). Clin Exp Rheumatol 2005; 23: 671-7.
10. Kanno Y, Kaneiwa A, Minamida M, Kanno M, Tomogane K, Takeuchi K, et al. The absence of uPAR is associated with the progression of dermal fibrosis. J Invest Dermatol 2008; 128: 2792-7.
11. Zhang G, Kim H, Cai X, Lopez-Guisa JM, Alpers CE, Liu Y, et al. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 2003; 14: 1254-71. (Pubitemid 36514666)
12. Bernstein AM, Twining SS, Warejcka DJ, Tall E, Masur SK,. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation. Mol Biol Cell 2007; 18: 2716-27.
13. Schneider UV, Nielsen RL, Pedersen C, Eugen-Olsen J,. The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms. BMC Infect Dis 2007; 7: 134.
14. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
15. Valentini G, Matucci Cerinic M,. Disease-specific quality indicators, guidelines and outcome measures in scleroderma. Clin Exp Rheumatol 2007; 25: 159-62.
16. Steen VD,. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35: 35-42.
17. Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ,. Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 1992; 35: 688-93.
18. Steen V, Denton CP, Pope JE, Matucci-Cerinic M,. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford) 2009; 48 Suppl 3: iii19-24.
19. Agarwal SK, Tan FK, Arnett FC,. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 2008; 34: 17-40.
20. Allanore Y, Dieude P, Boileau C,. Updating the genetics of systemic sclerosis. Curr Opin Rheumatol 2010; 22: 665-70.
21. Mondino A, Blasi F,. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 2004; 25: 450-5.
22. Binder BR, Mihaly J, Prager GW,. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost 2007; 97: 336-42.
23. Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, et al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford) 2010; 49: 1374-82.
24. McLaughlin V, Humbert M, Coghlan G, Nash P, Steen V,. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis. Rheumatology (Oxford) 2009; 48 Suppl 3: iii25-31.
25. Wipff J, Dieude P, Guedj M, Ruiz B, Riemekasten G, Cracowski JL, et al. Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. Arthritis Rheum 2010; 62: 3093-100.
26. Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Matucci-Cerinic M, et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 2010; 69: 1958-64.
27. Agarwal SK, Gourh P, Shete S, Paz G, Divecha D, Reveille JD, et al. Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis [published erratum appears in J Rheumatol 2010;37:1979]. J Rheumatol 2009; 36: 2715-23.
28. Manetti M, Liakouli V, Fatini C, Cipriani P, Bonino C, Vettori S, et al. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis. Ann Rheum Dis 2009; 68: 408-11.
29. Wipff J, Kahan A, Hachulla E, Sibilia J, Cabane J, Meyer O, et al. Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension. Rheumatology (Oxford) 2007; 46: 622-5.
30. Kawaguchi Y, Tochimoto A, Hara M, Kawamoto M, Sugiura T, Katsumata Y, et al. NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity. Arthritis Res Ther 2006; 8: R104.
31. Marasini B, Cossutta R, Selmi C, Pozzi MR, Gardinali M, Massarotti M, et al. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Clin Dev Immunol 2005; 12: 275-9.
32. Perneger TV,. What's wrong with Bonferroni adjustments. BMJ 1998; 316: 1236-8.
33. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010; 42: 426-9.
34. Stewart CE, Hall IP, Parker SG, Moffat MF, Wardlaw AJ, Connolly MJ, et al. PLAUR polymorphisms and lung function in UK smokers. BMC Med Genet 2009; 10: 112.